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1. Introduction 
The expectation of treatment goals in the management of gestational diabetes are the most 
stringent and precise for control of diabetes in adults (American Diabetes Association, 2011; 
Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2008). It is 
well accepted that the achievement of these goals requires an effective collaboration 
between a well-trained physician, a nurse educator and a qualified dietician experienced in 
working with pregnancy and, most importantly the woman with gestational diabetes 
(Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2008; 
Murphy, et al., 2010; Jacqueminet S, 2010; Kim, 2010; Kjos S, 1999). The more involved the 
woman becomes in her own treatment plan, the more likely that she will succeed (Meltzer S. 
J., 2010). 
2. Never underestimate the value of a well-planned, balanced diet 
Once a diagnosis of gestational diabetes has been made, the initial step is always an 
assessment of the woman’s present diet and the introduction of changes which would 
optimize her glucose control. Without an understanding and application of the concepts of 
medical nutrition therapy, further attempts at controlling glucose will always be limited. 
Individual dietary counselling with a trained dietician is preferable, whenever possible 
(Canadian Diabetes Association Clinical Practice Guidelines Expert Committee, 2008; 
International Diabetes Federation Writing Group, 2009).  
The major concepts of the diet consist of identifying fast and more slowly absorbed 
carbohydrate sources: fruits and vegetables, starchy foods such as bread, pastas, rice, 
noodles, grains, and milk and milk products as the major carbohydrate in the diet. In any 
one meal, optimally there is a small portion of fruits and/or vegetables which will be 
absorbed quickly, a portion of starches/grains which will be absorbed more slowly, 
accompanied by a portion of protein and a small portion of fat. The mix of two forms of 
carbohydrate absorbed over different time periods, as well as the presence of fat and protein 
which, apart from being essential nutrients, slow further the absorption of glucose from the 
gut permits a more gradual and slower rise of glucose post-meal. This makes glucose much 
easier to control with either endogenous insulin or injected forms – presented conceptually 
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in Figure 1. Additionally, use of foods with low glycemic index (higher in fibre and 
producing a lower post-ingestion glucose elevation) has been shown to be of help in 
minimizing effects of excess glucose in the pregnancy (Grant, Wolever, O'Connor, 
Nissenbaum, & Josse, 2011; Tzanetakou, Mikhailidis, & Perrea, 2011; Thomas D, 2009). 
Foetal growth, particularly asymmetric growth with increased central fat patterning relates 
to the effectiveness of glucose control of post-meal elevations and in general terms, excess 
post-prandial hyperglycaemia has negative effects on maternal and foetal well-being 
(Standl, Schnell, & Ceriello, 2011; Parretti, et al., 2001; DeVeciana, et al., 1995). 
In gestational diabetes, as with early type 2 diabetes, the first phase of insulin release is 
impaired (Ornoy, 2011; Catalano, Kirwan, Haugel-de Mouzon, & King, 2003), thus more 
concentrated forms of carbohydrate (sugar added to coffee, juices, candies, cakes etc.) will be 
absorbed too quickly for the slow insulin response, allowing the glucose to go up quickly to 
above normal levels which may then affect the baby. The stimulation of insulin release can 
occur in response to certain amino acids. There may still be an intact protein-stimulated 
insulin release response even if the glucose-stimulated insulin release is compromised 
which can help avoid elevated glucose values (Catalano, Kirwan, Haugel-de Mouzon, & 
King, 2003). These concepts are relatively simple to understand and when explained to the 
woman with GDM helps her to understand the basis of her dietary efforts and concerns. 
Providing an explanation to the woman with visual tools suggesting the relative absorption 
times and how different foods work will make it easier for her to understand what she is 
trying to do when she goes home and plans her meals. (Figures 1 and 2 developed for this 
purpose).  
 
 
 
Fig. 1.  
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Fig. 2.  
Author’s statement: Sara J. Meltzer, MD, FRCPC, FACP 
Figure 1 and 2 were developed by the author for use in clinical work teaching women with 
gestational diabetes the basic concepts of diet and are included here for those who may find 
them helpful. 
To be sure that the diet has been effectively instituted – using food diaries and encouraging 
measuring and weighing can be very helpful to help the women understand successes and 
problems with her choices of foods in her normal environment (Burke, Wang, & Sevick, 
2011). Unfortunately, some women will limit their food choices dramatically leaving out 
foods typical of their normal diet in an effort to reach glucose targets. Since it is important 
for the woman to understand how to incorporate the foods normally present in her diet 
including ethnically diverse foods while she has the help and time of a dietician’s advice 
and can see the effects on her glycemic control with frequent testing, excessive limitation of 
her food choices should be discouraged. The effectiveness of long-term dietary adjustments 
to decrease insulin need is more likely if she understands the effects of her preferred foods 
on her glucose control. Since the mother is often in charge of family meal-planning and 
cooking, her application of learned knowledge should help her avoid future diabetes and 
reduce the risks to her offspring whose eating habits develop at home (Ratner, et al., 2008; 
Tuomilehto, et al., 2001; Verier-Mine, 2010; Diabetes Prevention Program Research Group, 
2009; Egeland & Meltzer, 2010). 
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Pre-pregnancy BMI and actual weight gain are potentially modifiable risk factors so 
attention to both weight control pre-pregnancy and rate and total amount of weight gain in 
the pregnancy are important (Hutcheon, Platt, Meltzer, & Egeland, 2006; Radesky, Oken, 
Rifas-Shirman, Kleinman, Rich-Edwards, & Gillman, 2008). Recommended weight gain is 
often based on the Institute of Medicine recommendations, relate to pre-pregnancy BMI and 
intake will often be 25-30 kcal/kg (Institute of Medicine and National Research Council 
Committee to Re-examine IOM Pregnancy Weight Guidelines, 2009).  
3. Teach self-monitoring and establish glucose targets 
Another important facet of achieving glucose control will be to determine if the glucose 
values are appropriately controlled at various times of the day. In this situation, use of 
self-blood glucose monitoring (SBGM) is very effective. Avoiding starvation is also 
important so many centres will routinely test at some point for urine ketonuria to 
determine if the women are receiving adequate calories for their needs. The basic concepts 
of testing are easy to convey and ideally a qualified diabetes educator or pharmacist 
would review techniques in the use of the meter and lancet device chosen. In situations 
where this is not available, peer-to peer teaching may be equally effective.  It is valuable 
to verify the accuracy of the woman’s technique and device by asking her to do a 
comparative test against the laboratory value, ideally in a fasting state which provides a 
better comparator than in post-meal values which are in a state of flux and may differ in 
the capillary and venous system physiologically. This is important to clarify since the 
glucose targets required are within the normal range and many meters may have a small 
degree of consistent error which, if known, can be considered in defining her at-home 
meter glucose targets. 
The usefulness of the testing is markedly enhanced if the woman is instructed on how to use 
this information to adjust her therapy (Hawkins J. S., Casey, Lo, Moss, McIntyre, & Leveno, 
2009). The more pragmatic and useful the testing, the more likely compliance with 
management will be. Thus self-blood glucose monitoring is often done before breakfast and 
at 60-90 minutes after meals, since studies suggest that this is the highest level of glucose 
seen in the post-meal phase for the majority of women (Jovanovic L. G., 2008). The peak 
post-prandial glucose level in obese women tends to be higher and later - more around 90 
minutes after the meal (Ben-Haroush, Yogev, Chen, Rosenn, Hod, & Langer, 2004). In many 
parts of the world, the post-meal test timing recommended may be closer to 120 minutes or 
2 hours. Health providers must be aware that only testing before or after main meals may 
miss other parts of the day with significant increases in glucose so random testing at other 
times may also need to be suggested (Montaner, Ripolles, Pamies, & Corcoy, 2011)(29).  
In most national guidelines, the goal of therapy is to achieve values which fall into the 
normal range, thus under 5.1 or 5.3 mmol/L (92-95mg/dl) fasting, under 7.8mmol/L 
(140mg/dl) at 1h post load, and under 6.7mmol/L (120mg/dl) at 2h post-load (American 
Diabetes Association, 2011; Canadian Diabetes Association Clinical Practice Guidelines 
Expert Committee, 2008). It must be realized that these numbers indicate the mean plus two 
standard deviations above the mean… the actual mean is lower…usually between 3.8 – 4.4 
mmol/L in the fasting state and rarely above 6.5mmol/L at any point after the meal 
(Gillmer, Beard, Brooke, & Oakley, 1975; Parretti, et al., 2001; Rowan, Gao, Hague, & 
McIntyre, 2010; Yogev, Ben-Haroush, Chen, Rosenn, Hod, & Langer, 2004). Depending on 
the reliability of the individual, her meter accuracy and the evaluation of the pregnancy in 
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terms of weight gain, macrosomia and relative risks for the offspring, lower achieved values 
are often possible and near-normal values can often be reached using the right insulin 
protocol and self-adjustment of insulin by the patient.  There is no proven value of running 
blood glucose values at the top end of normal (or near the abnormal range) rather than the 
middle, so going for truly normal would appear to make sense if hypoglycemia does not 
occur. In a study of a Pima Indian cohort, diabetes conveyed excess offspring risk of obesity 
and glucose intolerance independent of genetic factors and other studies have explored the 
role of diet type and intake quantity in future offspring risks (Dabalea, et al., 2000; Reusens 
& Remacle, 2001). In fact, results of glucose targets achieved by any means in the MiG’s 
study (metformin in gestational diabetes) suggest that outcomes are optimal in terms of 
appropriate fetal weight for dates with values closer to the mean of normal (Rowan, Gao, 
Hague, & McIntyre, 2010) and a long-term follow-up study (15 years) attaining similar 
lower mean values led to a very low incidence (1%) of teenage offspring glucose intolerance 
(Egeland & Meltzer, 2010). In the HAPO study, there was an association with maternal post-
load glucose and clinical neonatal hypoglycemia; for the one hour glucose value (adjusted 
OR, 1.13; 95%CI; 1.03-1.26) and a weak association for the two hour glucose value (adjusted 
OR, 1.13; 95% CI 1.00-1.12) (HAPO Study Cooperative Research Group., 2009).  Even within 
normal ranges, maternal glucose values have been linked to offspring insulin sensitivity and 
beta cell function (Reusens & Remacle, 2001; Bush, Chandler-Laney, Rouse, Granger, Oster, 
& Gower, 2011). In obese women particularly, achievement of the optimal glucose targets 
improves fetal outcomes (Langer, Yogev, Xenakis, & Brustman, 2005). 
4. Physical activity should be encouraged unless precluded for obstetric 
reasons… 
The effectiveness of a physically active lifestyle has been shown to help prevent the 
development of type 2 diabetes in those at risk such as women diagnosed with gestational 
diabetes (Ratner, et al., 2008; Sanz, Gautier, & Hanaire, 2010).  Most guidelines recommend 
some form of regular exercise in pregnancy although only a few studies address this issue in 
detail (American Diabetes Association, 2011; Canadian Diabetes Association Clinical 
Practice Guidelines Expert Committee, 2008; Division of Nutrition PA, and Obesity, Centers 
for Disease Control; ACOG Committee Opinion, 2002; Bung, Artal, Khodiguian, & Kjos, 
1991; Artal, Lockwood, & Brown, 2010). At the very least, encouraging women to walk after 
meals often for a total of 30 minutes per day is the recommendation and this can improve 
glucose results and will help the women understand during pregnancy how effective small 
amounts of exercise can be on glucose control. Care must be used in women with evidence 
of pre-term labour or any previous suggestions of cervical incompetence; however this is the 
minority of women with gestational diabetes. 
5. Insulin adjustment algorithms with the patient self-adjusting are easy to 
teach and effective… 
Initiation of insulin, if needed, is no longer a reason to hospitalize a patient. Insulin is often 
needed in about 10-50% of women, depending on the population and the criteria used for 
diagnosis (Langer, Berkus, Brustman, Anyaegbunum, & Mazze, 1991). Once the effect of diet 
on initial testing has been evaluated and if the woman’s glucose values exceed the upper limits 
of glucose targets, it is a simple matter to initiate insulin in a logical and pragmatic way.  
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Consideration of the degree of macrosomia seen on ultrasound, particularly if increased 
abdominal girth is seen in the foetus may be used as a moderating factor in the need for 
initiation of insulin and potentially in the target glucose values aimed for (Buchanan, et al., 
1998)(44). The HAPO study showed a clear correlation with macrosomia and the glucose 
values attained on the oral glucose tolerance test result at 28-32 weeks [fasting glucose 
adjusted OR, 1.38; 95% CI:1.32-1.44, one-hour adjusted OR, 1.46  ; 95% CI 1.39-1.53, two-hour 
adjusted OR, 1. 38 ; 95% CI: 1.32-1.44] (HAPO Study Cooperative Research Group, Metger BE; 
Lowe LR; Dyer AR et al, 2008). If there is no evidence of macrosomia on ultrasound and the 
initial A1c is below a pregnancy normal mean of 5.3%, it may be possible to accept slightly 
higher glucose values and still obtain a good foetal outcome.  
The use of insulin pens has greatly simplified the teaching of insulin injection; however it is 
also relatively easy to teach injections using insulin syringes in a short teaching session, 
possibly in small groups. It is important that any woman being initiated on insulin (or any 
oral agent which is a secretogogue for that matter) be taught how to recognize and treat a 
hypoglycemic episode. The use of written and picture educational material often available 
from insulin producing companies will facilitate the educational essentials that must be 
explained. The concept of site use and rotation is another issue which should be addressed 
by the teaching nurse.  
There have been studies using both metformin and glyburide as oral agents for the 
management of gestational diabetes showing reasonably comparative composite outcomes. 
There were 46% of the women in the metformin study who still required insulin and there 
was inadequate power in the glyburide randomized trial to determine macrosomia and 
neonatal hypoglycemia outcomes (Rowan, Hague, Gao, Battin, Moore, & and MiG Trial 
Investigators, 2008; Langer, Conway, Berkis, Xenakis, & Gonzales, 2000). At present in most 
countries, it remains “off-label” and most guidelines do not suggest its routine use or only if 
for some reason insulin cannot be used (American Diabetes Association, 2011; Canadian 
Diabetes Association Clinical Practice Guidelines Expert Committee, 2008; Jacqueminet S, 
2010). For these reasons, it will not be addressed in detail in this chapter. 
In terms of the actual insulin prescription, the concept of using a famous train robber’s 
recommendation - Sutton’s law “Go where the money is!” can be very helpful. In other words, 
pick the part of the day which is most abnormal from the point of view of glucose control. In 
general, improvement to absolutely normal of the fasting glucose value will facilitate the 
release of insulin by the woman and improve glucose much of the day (Pennartz, Schenker, 
Menge, Schmidt, Nauck, & Meier, 2011). In the majority of cases, bedtime insulin is the most 
effective first step although the women from South East Asia and Asia may have post-meal 
glucose which tends to be higher and may have normal fasting glucose values.  
If the fasting glucose is the value which is above range, initiation of intermediate insulin at 
bedtime (neutral protamine Hagedorn or NPH in human or pork form) at a low dose should 
be done (can be as low as 2 units in a very nervous woman who is not too obese, but the 
usual starting dose would be 8 – 10 units minimum or 0.1 units/kg).  In many clinics, the 
women return on a regular basis for adjustment of their insulin doses. As insulin needs 
increase progressively in response to placental growth and production of anti-insulin 
hormones, this often means that the initial period after adjustment is well controlled but 
over the two weeks the glucose control may deteriorate. It is very easy to have the women 
do the progressive adjustment of her own insulin based on her morning blood glucose (and 
thus her body’s response to the insulin given); she can then increase the dose by specified 
increments until she achieves the desired range. The increments are largest for high glucose 
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values (as much as 6 units at once) and gradually reduce to as little as 1 unit more insulin for 
the evening dose as the target range is reached (See Figure 3a).  In someone who is markedly 
obese or may have evidence of acanthosis nigricans, often an initial dose may be 0.1-0.2 
units/kg administered at bedtime again with an increase in dose the following day if the 
fasting glucose has not achieved the desired range. An important part of the algorithm is a 
glucose value below which she MUST REDUCE her evening dose of NPH. This avoids 
hypoglycaemia before it happens and discourages overzealous increases in insulin dosages. 
Our experience has been very effective and safe using the value of 4.2mmol/L below which 
a woman will reduce that night’s dose as this glucose value is far away from the values of 
3.2 or 2.8mmol/L which would be felt as a hypoglycemic reaction and require treatment 
(Snyder, Gray-Donald, & Koski, 1994; Meltzer, Snyder, Penrod, Nudi, & Morin, 2010).  
In situations where women have markedly elevated fasting and post-meal glucose levels, an 
overall dose of 0.5 – 0.7u/kg can be used in the proportion of about 40% as bedtime NPH 
insulin and the remainder split over the day with a bit more at breakfast and less at lunch ie. 
25% - 15% - 20% of the total calculated dose given as regular or rapid-acting insulin prior to 
breakfast, lunch and dinner respectively. 
On very rare occasions likely explaining the lack of literature related to it, women develop a 
local allergy to NPH at the injection site with swelling and redness developing up to 12 
hours after the last injection of NPH at that site and lasting for about one to two days. In 
virtually every situation where this has been seen and is deemed intolerable by the woman, 
switching to regular human insulin as a 10pm injection and retesting glucose at 0400 to 
adjust the 10 pm dose as well as adding a 0400h injection of human (preferably) or pork 
regular insulin which will be adjusted based on the pre-breakfast result will often correct the 
allergy problem and continue to effectively control the glucose.  Usually the dose can be 
reduced from the previous insulin dose and given as one third at 2200h and about one third 
or a bit less at 0400h. Subsequent self-adjustment protocols can still be used with an added 
time of 0400h and will allow for safe correction of insulin to optimal doses. Unfortunately, 
this approach does interfere with the woman’s sleep. The use of detemir or glargine insulin 
may be alternatives; however it has yet to be reported in this situation. 
If the fasting glucose is normal and the post-meal is the glucose which is elevated (often 
related to ethnic differences), the insulin administered will be regular insulin or a rapid-
acting analogue administered prior to the meal (See Figure 3b). If Regular insulin is used, 
the time it should be taken before the meal is often 20-30 minutes, which is why the rapid-
acting analogues are often preferred, as they can be take much closer to the meal (0-15 
minutes) and still effectively control the post-prandial 60-90 minute peak (Pettitt, Ospina, 
Kolaczynski, & Jovanovic, 2003). The effectiveness of the dose is evaluated by the woman 
using her post-meal glucose value for that meal and the following day, the dosage for that 
meal will be adjusted up or down in order to achieve the desired values. Since at meals, 
occasionally, even the “best” patient may change her food from the recommended meal 
plan, it is often appropriate to wait for 2 abnormal values before increasing the dose, 
however only one value lower than the desired goal requires that the dose be reduced the 
following day. Allowing the woman to be responsible for the gradual and persistent 
adjustments of insulin dose regularly seen in GDM as the placenta continues to grow and 
her insulin needs rise can facilitate her care. Occasional additional tests in relation to snacks 
or prior to meals may be necessary to determine glucose control is always good (Montaner, 
Ripolles, Pamies, & Corcoy, 2011). Visits may be further apart because the woman is making 
the appropriate adjustments, thus the medical team does not need to. Use of colour-coding 
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has been useful in women whose understanding of the language may be limited so that 
even women not easily able to read and write have been able to make use of this protocol 
(Figure 3c). Occasionally, there are women who feel much too insecure to adjust, or simply 
cannot seem to understand the algorithm. In cases like these, the medical team (diabetes 
nurse educator and physician) will, of necessity, need to make the adjustments and thus, 
likely require more frequent visits. This is the exception rather than the rule. 
Thus, the patient can continue to adjust her insulin appropriately, gradually increasing the 
insulin doses until between 34-37 weeks, where some decrease in insulin requirements is 
often seen as the baby is now bigger and eats more, so siphons off glucose most obviously 
overnight when the patient is not eating but the baby still is. In addition, the placenta is no 
longer growing and may be aging, so the placental hormones which have been increasing 
insulin resistance are gradually decreasing. In fact, an early or dramatic fall in insulin 
requirements may be an early manifestation of a placental problem and may help alert the 
health professionals.  
 
 
Fig. 3.  
6. Approaching the finish line – what to do for labour and delivery 
There are few papers determining the effectiveness of specific protocols for use in labour 
where the protocols specifics are detailed (Palmer & Inturissi, 1992; Ramanathan, Khoo, & 
Arismendy, 1991; Leparcq, et al., 2008; Jovanovic & Petersen, 1983; Hawkins & Casey, 2007). 
In 1983, using a Biostator®, Jovanovic and Peterson determined that the average hourly 
need for glucose to cover the needs of labour was 2.55 mg/kg/min (Jovanovic & Petersen, 
1983). When translated into the approximate hourly rate for a 70kg woman, this would 
mean 9.45g/hour as an infusion rate. This would require very large amounts of fluids or 
perhaps a central line to provide such glucose-intense amounts in a normal clinical setting. 
The majority of the recommended and detailed protocols have been used in type 1 diabetic 
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patients. In the diabetes and pregnancy clinics today, many of the patients have type 2 
diabetes with significantly more insulin resistance and a high total daily dose (TDD). 
Additionally, many women with gestational diabetes picked up in pregnancy may have 
glucose abnormalities outside of pregnancy and significant underlying insulin resistance. 
The majority of protocols presume that the hourly needs for insulin are always the same in 
labour; however, it may be more appropriate to use a gradually adjusting protocol based on 
insulin need in patients with type 2 or gestational diabetes. 
For these reasons, we have developed a protocol based on the patient’s total daily dose to 
provide the initial insulin infusion rate. As a compromise for fluid use, not only for glucose 
provision, but potentially for oxytocin induction or other fluids needed for obstetric reasons, 
the protocol developed provides 5g/h of glucose in the form of dextrose 10% at 50 ml/hour 
beginning on the morning of induction or Caesarean section, or when the patient arrives in 
labour. Since labour is a significant activity, the obstetricians are encouraged to provide a 
consistent amount of at least 5g of glucose to be delivered per hour to avoid fatigue and 
ketosis. If the glucose value exceeds 4.5mmol/L (81mg/dl), an insulin infusion is begun.  
For women with gestational diabetes, an insulin infusion protocol is not provided if the total 
daily dose is less than 30 units per day. If above 30 units, the total number of units taken in 
the day is divided in half (since about half of the insulin she takes will be to cover meals) 
and the remaining insulin dose is divided by 24 to permit the determination of a starting 
dose in units per hour.  
The insulin dose is adjusted hourly keeping the amount glucose infused stable and realizing 
that insulin requirements usually fall in labour. If there is a fall of glucose to under 
4.0mmol/L (72mg/dl), the dose is reduced quickly, below 3.5mmol/L (63mg/dl)…even 
more and at 3.0mmol/L, the insulin is stopped – glucose in the form of 50% dextrose is 
given to provide 10 gm of immediate glucose (i.e. 20 ml.) and repeated every 10 minutes 
until the glucose rises above 4.5mmol/L (81mg/dl). If the glucose rises, the dose is increased 
incrementally until a steady state is reached. In our hospital protocol, we aim for a glucose 
between 4.0 – 5.5mmol/L (72 – 100 mg/dl) during labour using this protocol, with success 
and minimal hypoglycaemia, however this is due to intensive in-house review of the 
protocol on a regular basis and consistency over 20 years. The entire protocol is pre-printed 
in the clinic prior to labour using dosages at about 36-37 weeks and the women is given a 
copy to present on arrival in the delivery room.  
As part of a quality assessment program, we retrospectively evaluated the effectiveness of 
this protocol for labour and delivery in use 20 years in our institution for glucose control in 
women with type 1, type 2 and gestational diabetes. Ethical approval of the assessment and 
chart review was obtained from the McGill University Health Center Ethics Board. Women 
who delivered for the years 2004-2006 and were treated with an insulin dose ≥ 30units/day 
prior to labour and managed with an intra-partum protocol were included. Patients were 
excluded if they did not receive the insulin protocol due to precipitated labor of urgent CS 
or if the chart was missing vital maternal or neonatal data. 
The protocol includes a glucose infusion of 5g/h as 10% dextrose in water and an insulin 
infusion using ½ of the TDD/24 as the initial hourly rate was begun if CBGM was 
≥4.5mmol/L and adjusted to maintain glucose between 4.5-5.5mmol/L. At placental 
delivery, insulin is held and glucose increased to 10g/h until glucose goes above 
5.5mmol/L. A total of 80 women were evaluated in 86 pregnancies. Of those, 31(39%) had 
type 1 DM with mean BMI 21.7, 9 with microvascular complications, mean duration of DM 
14.6 years, 43% had Caesarian sections.  The mean A1C by trimester was: T1 6.3%, T2 5.5%, 
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T3 5.3%. The mean FPG by trimester of T1 7.0, 6.0, 5.6 mmol/L respectively; mean 1hPC T1 
7.3 T2 6.2  T3 6.0  mmol/L and insulin was administered in 90% of labours. The 49(61%) 
women with type 2 DM had a mean BMI of 33kg/m2, a mean duration of DM of 3.3years, 2 
with microvascular complications, and 76% had Caesarian sections. The mean A1C by 
trimester was T1 8.5%, T2 7% and T3 6.7%. The mean FPG by trimester was: T1 7.7, T2 6.3, 
T3 5.5mmol/L, and the mean 1hPC T1 9.6, T2 7.0, T3 7.2 mmol/L and insulin infusion was 
used in 72% of cases.  
 
 
Fig. 4. 
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Mean insulin dose in labour was 1.73units/h for DM1, 2.2unit/h in DM2. Maternal 
hypoglycemia (CBG <3.3 mmol/L) occurred in 16% of labour occurring equally in DM1 or 
DM2, however there were only 4 episodes of maternal hypoglycemia <2.5mmol/L. Mean 
glucose achieved overall was 5.8mmol/L (6.1mmol/L for DM1; 5.6mmol/L for DM2). Of 
the 863 CBG readings, there were 31% between 4.5-5.5mmol/L, 24% lower, and 43% higher 
with 9% ≥7mmol/l (See Figure 5). Neonatal hypoglycaemic events (BS ≤2.2mmol/L 
occurred in 32 neonates (37% - 46% in DM1 offspring, 40% in DM2 offspring (p=0.047) and 
4(12%) in babies whose mother did not receive maternal IV insulin. No significant 
relationship was seen between glucose control in labour, nor in any trimester in labour and 
neonatal hypoglycemia. The results of the glucose control can be seen in Figure 6. The 
findings suggest that this relatively simple protocol which can be prepared by house-staff 
based on total daily dose was able to safely control both DM1 and DM2 /gestational 
diabetic women with minimal hypo or hyper-glycemic risk for mother or offspring. The 
degree of glucose control in labour did not appear to relate to the risk of hypoglycemia in 
the neonate in this sample size. (Figure 5) 
Once the baby has been delivered, the needs for insulin fall faster than the insulin is 
metabolized, so the women is at risk of hypoglycaemia in the first 1-2 hours after delivery. 
Thus, the protocol emphasizes stopping the insulin at delivery and increasing the glucose 
infusion to 10g/hour immediately after the delivery of the baby and for the next 2 hours. If 
the glucose remains above 5.5mmol/L, the infusion rate can be reduced to 5g an hour again 
or discontinued and the woman would be allowed to eat if she underwent a vaginal 
delivery. As most women with gestational diabetes have normal glucose post-partum, this 
can be checked with capillary blood glucose monitoring (CBGM) the following day pre and 
post breakfast. If there is evidence of abnormal glucose intolerance (particularly in someone 
who may have had type 2 diabetes only diagnosed in pregnancy) in the initial post-partum 
period, depending on its severity, the woman may be instructed to continue with medical 
nutrition therapy and testing and re-assess in 1 month, or she may require some form of 
therapy with oral agents or insulin on leaving the hospital.  
If her glucose appears normal prior to discharge, she should undergo an OGTT at 6 weeks to 
6 months post-partum (or before she next conceives) to verify her glucose tolerance status – 
the actual timing varies related to guidelines established in various countries and related to 
the ethnic risks present in that country (Canadian Diabetes Association Clinical Practice 
Guidelines Expert Committee, 2008; Reinblatt, Morin, & Meltzer, 2006; McClean, Farrar, 
Kelly, Tuffnell, & Whitelaw, 2010). Initial post-partum testing within the first year is most 
effective if an oral glucose tolerance test is done; however, of those with any abnormality, 
further regular follow-up is likely adequate with a fasting plasma glucose and potentially an 
A1C (Lee, Mak, Lao, & Chung, 2011; Kim, Herman, & Vijan, 2007). Many women with GDM 
will have evidence of some form of dysglycemia or impaired glucose tolerance which would 
be amenable to preventive therapy. Additionally, even for women who tested normal, they 
must be reminded that their long term risks of developing diabetes remain elevated as does 
their cardiovascular risks (Egeland & Meltzer, 2010; Bellamy, Casas, Hingorani, & Williams, 
2009; Ratnakaran, Qi, Connelly, Sermer, Hanley, & Zinman, 2010). It should not be forgotten 
that the presence of gestational diabetes in the mother appears to confer future risk for the 
offspring in terms of obesity and glucose intolerance (Nolan, Damm, & Prentki, 2011; 
Deierlein, Siega-Riz, Chantala, & Herring, 2011). 
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Fig. 5. Glucose values achieved in labour with insulin adjustment protocol and incidence of 
neonatal hypoglycemia. 
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Fig. 6. Mean capillary blood glucose in labour in women with type 1 or type 2 DM  
In the appendix there are copies of the insulin adjustment algorithm, document sheets for 
management in English and French and in-hospital insulin algorithms for day by day 
management and for insulin in  labour protocol. 
7. Conclusion  
Management of gestational diabetes can be very rewarding.  This chapter has tried to raise 
the important issue that implication of the woman enthusiastically in her own self-care can 
facilitate care and become a tool to sensitize her to her future role in the family lifestyle 
choices. 
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9. Appendix 1  
Insulin adjustment protocol in English 
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10. Appendix 2  
 
 
 
 
 
 
 
Documentation sheet for capillary blood glucose and insulin adjustment in English and 
French 
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11. Appendix 3 
Insulin adjustment protocol for use in hospital 
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